Beleave Provides Update on B.C. Indoor Facilities
TORONTO, Oct 1, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the
"Company") is pleased to announce that it is has filed an application with Health Canada and, once
approved, is ready to proceed with phase one in Chilliwack of the its recently-announced indoor cultivation
cannabis project in British Columbia.
Less than two weeks ago, the Company announced the ambitious new project, jointly-designed by Beleave
and Kannavis Biotech Corp., on a 50/50 operating expenditure and revenue partnership, that will
encompass a total of ten indoor growing facilities approximately 87,000 square feet each.
This project is fully capitalized and will carry newest products including strains of cannabis not yet offered
in Canada, as well processing of newly acquired and developed products that will include edibles, drinks,
and other non-combustible cannabis products that Beleave will be releasing to the general public in the
near future.
"We're very pleased with our progress, and we anticipate receiving the approval from Health Canada," said
Andrew Wnek, Beleave CEO. "Once completed, the entire project will add hundreds of thousands of
square feet of superior indoor grow space to our growing capacity. We will continue to update our
stakeholders on its progress as developments arise."
The company plans to have phase one fully built, outfitted, and producing cannabis for Q2 2019.
ABOUT BELEAVE INC.
Beleave is a vertically-integrated Canadian cannabis company headquartered in Oakville, Ontario, that
operates streamlined facilities throughout Canada to cultivate high-quality cannabis flower, oil, and extracts
with funded capacity in excess of 150,000 kg per year.
Fully-licensed to cultivate and sell medical and recreational cannabis, Beleave is leading the way through
research partnerships with universities to bridge the gap between science and tradition and to develop
pharma-grade extracts and derivatives. Beleave is currently developing new product lines for October 2019
as the recreational market is expected to allow for food and beverage-based cannabis products.
Beleave is growing its storefront and online sales presence rapidly through its wholly-owned subsidiaries,
Beleave Kannabis Corp. and Seven Oaks, which are licensed for medicinal and recreational sales
respectively. The company's first retail location is opening this fall in Llyodminster, Saskatchewan. Beleave
has also developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green
banner.
Through its majority ownership of Procannmed S.A.S., Beleave has access to 27 hectares of outdoor grow
space and is fully licensed to cultivate, produce, extract and distribute medical cannabis in Colombia to
capitalize on exports and the expanding Latin American market.
